希鲁丁用于治疗慢性病的治疗
Sai-Ji Liu1, Yi-Ling Cao1, Chun Zhang1
1Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Molecules (Basel, Switzerland)
|March 13, 2024
概括
天然希鲁丁是希鲁多医学的血栓抑制剂,显示出对慢性病 (CKD) 的保护作用. 它通过减少炎症和细胞亡来对抗纤维化.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 慢性病 (CKD) 是一个重大的全球健康挑战,随着病率和死亡率的增加.
- 纤维化,包括淋巴结核硬化,管状缩和间歇性纤维化,是CKD的标志性病理.
- 目前对CKD的治疗选择存在局限性,需要新的治疗策略.
研究的目的:
- 审查天然希鲁丁在治疗慢性病中的治疗潜力.
- 阐明hirudin在各种形式的CKD中发挥保护作用的机制.
- 总结一下希鲁丁对CKD治疗的有益特性.
主要方法:
- 对药理学数据和科学文献的审查.
- 对希鲁丁对血栓的抑制作用的分析.
- 检查希鲁丁对炎症反应,亡以及细胞中蛋白酶激活受体相互作用的影响.
主要成果:
- 希鲁丁是一种强大的天然血栓激素抑制剂,在CKD的临床前模型中显示出显著的保护作用,包括糖尿病病和性综合征.
- 关键的机制包括抑制炎症途径,预防细胞亡,以及干扰血栓因子受体信号传递.
- 希鲁丁有效地减轻脏间歇性纤维化,这是CKD进展的关键因素.
结论:
- 天然希鲁丁在治疗慢性病方面具有相当大的治疗前景.
- 它的多方面的机制,包括抗炎和抗亡作用,有助于其保护性质.
- 对希鲁丁的进一步研究可能会导致对抗纤维化和CKD的新型治疗策略.
相关概念视频
01:27Dialysis
309
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
309
01:22Heart Failure Drugs: Diuretics
370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370
01:11Renal Failure: Dose Adjustments
88
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
88
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
428
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
428
01:17Factors Affecting Renal Clearance: Renal Impairment
91
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
91
01:25Antihypertensive Drugs: Direct Renin Inhibitors
621
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
621